Analysis of exocrine pancreatic tumors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

PATAKESS is a non-interventional cohort study that analyzes clinical and biological data from patients with exocrine pancreatic tumors. It includes both prospective data from living patients and retrospective data from deceased patients whose tumor samples were collected during routine healthcare. The study aims to correlate biological characteristics of the tumors with clinical outcomes, focusing on the interactions between tumor cells and the surrounding stroma. This research is crucial for understanding the aggressive nature of pancreatic adenocarcinoma and improving therapeutic strategies.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Male or female patient 18 age or older
* Patient operated on for exocrine pancreatic adenocarcinoma at Centre Léon Bérard since 01/01/2010.
* Histological diagnosis of exocrine pancreatic adenocarcinoma confirmed with surgery specimen.

Exclusion Criteria:

* Not applicable

Where it's running

• Centre Léon Bérard
  Lyon, France Recruiting

Study contacts

• Principal investigator: Philippe CASSIER — Centre Leon Berard
• Study coordinator: Philippe CASSIER
• Email: philippe.cassier@lyon.unicancer.fr
• Phone: 04 26 55 68 33

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Gastric Cancer Clinicobiological Cohort Study

  This study tests the tumor microenvironment in gastric and gastroesophageal junction cancers from patients who had surgery after standard neoadjuvant chemotherapy at a single center.

  Recruiting Centre Leon Berard · Lyon · NCT07787052

• Impact of Exercise on Tumor Immunity in NSCLC Patients Receiving Neoadjuvant Chemo-Immunotherapy

  A structured exercise program is being tested to see if it boosts immune cells in the tumor for patients with resectable NSCLC undergoing pre-surgery chemo-immunotherapy.

  Recruiting at 2 sites Centre Leon Berard · Lyon, Rhône and 1 other locations · NCT07786909

• Canut Junior: Testing Sensory Changes and Eating in Kids with Cancer

  This feasibility study tests whether we can measure taste, smell, saliva, and food preferences in children and teens undergoing cancer treatment to see if it’s doable in real-world care.

  Recruiting Centre Leon Berard · Lyon · NCT07632560

• How health and motivation change during the 13-week KHEOPS physical activity program for women treated for breast cancer

  This study will see how clinical symptoms and motivation change during a 13-week KHEOPS physical activity program for women with non-metastatic breast cancer.

  Recruiting Centre Leon Berard · Lyon · NCT07515326

• Increasing HPV vaccination among middle and high school students in Auvergne-Rhône-Alpes

  This project will try a school-based HPV prevention program to see if it increases vaccination rates among 11–17-year-old students in the Auvergne-Rhône-Alpes region.

  Recruiting Centre Leon Berard · Saint-Priest · NCT07414719

• How venetoclax blood levels relate to treatment response in acute myeloid leukemia

  This project will test how blood levels of venetoclax relate to treatment effects in adults with AML who are starting venetoclax plus azacitidine.

  Recruiting at 5 sites Centre Leon Berard · Bourgoin, France and 4 other locations · NCT07243483

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.